Emergent BioSolutions Inc.

8-K Entered a material agreement; Regulation FD disclosure Jun 29, 2026 10-Q Quarter ended 2026-03-31 May 1, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Apr 30, 2026 8-K Shareholder vote results Apr 30, 2026 8-K Entered a material agreement; Terminated a material agreement; Unregistered sale of equity; Regulation FD disclosure Apr 17, 2026 8-K Director or officer change; Regulation FD disclosure Mar 3, 2026 10-K Fiscal year ended 2025-12-31 Feb 27, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Feb 26, 2026 8-K Regulation FD disclosure Jan 14, 2026 8-K Regulation FD disclosure Jan 12, 2026 8-K Regulation FD disclosure Dec 12, 2025 8-K Director or officer change; Regulation FD disclosure Nov 12, 2025 10-Q Quarter ended 2025-09-30 Oct 30, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Oct 29, 2025 8-K Entered a material agreement; Regulation FD disclosure Sep 11, 2025 8-K Other events Sep 5, 2025 10-Q Quarter ended 2025-06-30 Aug 7, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Aug 6, 2025 8-K Other events Jun 24, 2025 8-K Other events May 23, 2025 10-Q Quarter ended 2025-03-31 May 8, 2025 8-K Results of operations (earnings release); Regulation FD disclosure May 7, 2025 8-K Shareholder vote results May 6, 2025 8-K Other events Mar 31, 2025 8-K Other events Mar 24, 2025 8-K Regulation FD disclosure; Other events Mar 10, 2025 10-K Fiscal year ended 2024-12-31 Mar 4, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Mar 3, 2025 8-K Regulation FD disclosure Jan 15, 2025 8-K Other events Jan 14, 2025 8-K Other events Jan 8, 2025 10-Q Quarter ended 2024-09-30 Nov 7, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Nov 6, 2024 8-K Director or officer change Oct 4, 2024 8-K Entered a material agreement; Results of operations (earnings release); Took on a direct financial obligation; Regulation FD disclosure Oct 2, 2024 8-K Unregistered sale of equity Sep 17, 2024 8-K Entered a material agreement; Terminated a material agreement; Took on a direct financial obligation; Unregistered sale of equity; Regulation FD disclosure; Other events Sep 3, 2024 8-K Regulation FD disclosure; Other events Aug 30, 2024 8-K Regulation FD disclosure; Other events Aug 20, 2024 10-Q Quarter ended 2024-06-30 Aug 7, 2024